Data / Form D filings / Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc.: Form D filings
Capstan Therapeutics, Inc., a biotechnology company in San Diego, CA, filed 3 Form D notices with the SEC in 2024. The latest, on March 20, 2024, reports $87.5 million sold of a $175 million offering to 21 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9880 CAMPUS POINT DRIVE, SUITE 220, San Diego, CA, 92121
- Phone
- (858) 314-9188
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2015437
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 20, 2024 | New notice | $174,999,964 | $87,499,982 | $87,499,982 | 21 | Mar 5, 2024 | sec.gov |
| Mar 20, 2024 | New notice | $101,999,962 | $76,499,983 | $25,499,979 | 14 | Jun 14, 2022 | sec.gov |
| Mar 20, 2024 | New notice | $62,999,992 | $62,999,992 | 9 | Nov 24, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Fabio Pucci | Director | |
| Nandita Shangari | Director | |
| Michal Silverberg | Director | |
| Erez Chimovits | Director | |
| Athena Countouriotis | Director | |
| Rajul Jain | Director | |
| Laura Shawver | Executive Officer, Director | |
| Ramin Farzaneh-Far | Executive Officer | |
| Justin Thacker | Executive Officer | |
| Michael Baran | Director | |
| Adrian Bot | Executive Officer | |
| Nanna Luneborg | Director | |
| Priya Karmali | Executive Officer | |
| Karen Smith | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Mar 18, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Capstan Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.